Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Sarepta
Pharma
Sanofi sues Sarepta over 2 gene therapy manufacturing patents
Sanofi has filed a complaint claiming that in producing Duchenne muscular dystrophy treatment Elevidys, Sarepta encroaches on two of its patents.
Kevin Dunleavy
Jul 30, 2024 5:21pm
FDA broadens label for Sarepta's Duchenne gene therapy Elevidys
Jun 21, 2024 7:51am
Evidence pushes back on FDA's use of surrogate markers: report
May 29, 2024 11:25am
NS Pharma's Duchenne drug Viltepso flunks confirmatory trial
May 28, 2024 11:54am
Sarepta's Elevidys off to strong start despite label restriction
Nov 2, 2023 4:21pm
Catalent faces new possible 'cliff' after Sarepta miss: analyst
Nov 1, 2023 8:50am
